NORTHERA Drug Patent Profile
✉ Email this page to a colleague
When do Northera patents expire, and what generic alternatives are available?
Northera is a drug marketed by Lundbeck Na Ltd and is included in one NDA.
The generic ingredient in NORTHERA is droxidopa. There are six drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the droxidopa profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Northera
A generic version of NORTHERA was approved as droxidopa by AJANTA PHARMA LTD on February 18th, 2021.
Summary for NORTHERA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 92 |
| Clinical Trials: | 17 |
| Patent Applications: | 341 |
| Drug Prices: | Drug price information for NORTHERA |
| What excipients (inactive ingredients) are in NORTHERA? | NORTHERA excipients list |
| DailyMed Link: | NORTHERA at DailyMed |
Recent Clinical Trials for NORTHERA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| H. Lundbeck A/S | Phase 2 |
| Loma Linda University | Phase 2 |
| Stephen G. Kaler, MD | Phase 1/Phase 2 |
Pharmacology for NORTHERA
| Physiological Effect | Increased Blood Pressure |
Anatomical Therapeutic Chemical (ATC) Classes for NORTHERA
US Patents and Regulatory Information for NORTHERA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lundbeck Na Ltd | NORTHERA | droxidopa | CAPSULE;ORAL | 203202-001 | Feb 18, 2014 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Lundbeck Na Ltd | NORTHERA | droxidopa | CAPSULE;ORAL | 203202-002 | Feb 18, 2014 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Lundbeck Na Ltd | NORTHERA | droxidopa | CAPSULE;ORAL | 203202-003 | Feb 18, 2014 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
